Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 2301 | 15.09 |
09:34 ET | 1011 | 14.9422 |
09:36 ET | 700 | 14.98 |
09:38 ET | 200 | 15.0028 |
09:39 ET | 4341 | 15.07 |
09:41 ET | 200 | 15.03 |
09:43 ET | 2870 | 15.16 |
09:45 ET | 400 | 15.12 |
09:48 ET | 200 | 15.1217 |
09:50 ET | 400 | 15.125 |
09:52 ET | 600 | 15.125 |
09:54 ET | 300 | 15.0515 |
09:56 ET | 782 | 15.09 |
09:57 ET | 100 | 15.105 |
09:59 ET | 200 | 15.125 |
10:01 ET | 300 | 15.11 |
10:03 ET | 100 | 15.075 |
10:06 ET | 302 | 15.09 |
10:08 ET | 1200 | 15.07 |
10:10 ET | 100 | 15.06 |
10:12 ET | 1500 | 14.985 |
10:15 ET | 500 | 15 |
10:17 ET | 250 | 15.05 |
10:19 ET | 549 | 15.06 |
10:21 ET | 3706 | 15.05 |
10:24 ET | 5632 | 15.04 |
10:26 ET | 603 | 15.02 |
10:28 ET | 1157 | 15.05 |
10:30 ET | 100 | 15.05 |
10:32 ET | 1567 | 15.09 |
10:33 ET | 425 | 15.1585 |
10:37 ET | 275 | 15.1618 |
10:39 ET | 1309 | 15.2 |
10:44 ET | 200 | 15.19 |
10:46 ET | 416 | 15.17 |
10:48 ET | 943 | 15.11 |
10:51 ET | 200 | 15.13 |
10:55 ET | 100 | 15.13 |
10:57 ET | 400 | 15.15 |
11:02 ET | 100 | 15.16 |
11:04 ET | 300 | 15.11 |
11:09 ET | 500 | 15.165 |
11:13 ET | 200 | 15.185 |
11:15 ET | 1766 | 15.155 |
11:18 ET | 100 | 15.155 |
11:20 ET | 1526 | 15.11 |
11:22 ET | 12400 | 15.32 |
11:24 ET | 2562 | 15.25 |
11:26 ET | 300 | 15.245 |
11:29 ET | 209 | 15.245 |
11:31 ET | 3348 | 15.26 |
11:33 ET | 500 | 15.26 |
11:36 ET | 200 | 15.255 |
11:38 ET | 8267 | 15.12 |
11:44 ET | 844 | 15.15 |
11:49 ET | 212 | 15.19 |
11:54 ET | 11052 | 15.023 |
12:02 ET | 500 | 14.96 |
12:03 ET | 110 | 14.955 |
12:12 ET | 100 | 14.93 |
12:14 ET | 400 | 14.91 |
12:16 ET | 200 | 14.93 |
12:18 ET | 1923 | 14.93 |
12:21 ET | 500 | 14.926 |
12:23 ET | 804 | 14.9 |
12:25 ET | 209 | 14.8852 |
12:27 ET | 400 | 14.89 |
12:30 ET | 300 | 14.88 |
12:32 ET | 1680 | 14.82 |
12:34 ET | 1370 | 14.87 |
12:36 ET | 1206 | 14.95 |
12:38 ET | 715 | 14.895 |
12:39 ET | 500 | 14.895 |
12:41 ET | 300 | 14.89 |
12:43 ET | 600 | 14.87 |
12:45 ET | 300 | 14.86 |
12:48 ET | 500 | 14.85 |
12:50 ET | 300 | 14.85 |
12:52 ET | 200 | 14.85 |
12:54 ET | 310 | 14.87 |
12:56 ET | 200 | 14.85 |
12:57 ET | 828 | 14.865 |
12:59 ET | 200 | 14.85 |
01:01 ET | 976 | 14.86 |
01:03 ET | 702 | 14.875 |
01:06 ET | 512 | 14.83 |
01:08 ET | 300 | 14.82 |
01:10 ET | 300 | 14.82 |
01:12 ET | 569 | 14.8832 |
01:14 ET | 200 | 14.85 |
01:15 ET | 1200 | 14.87 |
01:17 ET | 1771 | 14.82 |
01:19 ET | 335 | 14.81 |
01:21 ET | 300 | 14.81 |
01:24 ET | 711 | 14.82 |
01:26 ET | 300 | 14.84 |
01:28 ET | 205 | 14.865 |
01:30 ET | 300 | 14.85 |
01:32 ET | 1287 | 14.84 |
01:33 ET | 200 | 14.83 |
01:35 ET | 583 | 14.841 |
01:37 ET | 827 | 14.83 |
01:39 ET | 3627 | 14.75 |
01:42 ET | 865 | 14.77 |
01:44 ET | 582 | 14.78 |
01:46 ET | 1109 | 14.75 |
01:48 ET | 480 | 14.7758 |
01:50 ET | 1910 | 14.8 |
01:51 ET | 200 | 14.78 |
01:53 ET | 269 | 14.78 |
01:55 ET | 675 | 14.78 |
01:57 ET | 790 | 14.76 |
02:00 ET | 300 | 14.76 |
02:02 ET | 200 | 14.75 |
02:04 ET | 5598 | 14.74 |
02:06 ET | 938 | 14.75 |
02:08 ET | 1011 | 14.78 |
02:09 ET | 243 | 14.77 |
02:11 ET | 2619 | 14.795 |
02:13 ET | 300 | 14.8 |
02:15 ET | 413 | 14.81 |
02:18 ET | 1814 | 14.83 |
02:20 ET | 400 | 14.82 |
02:22 ET | 2086 | 14.815 |
02:24 ET | 1379 | 14.82 |
02:26 ET | 234 | 14.82 |
02:27 ET | 400 | 14.81 |
02:29 ET | 300 | 14.81 |
02:31 ET | 842 | 14.81 |
02:33 ET | 300 | 14.81 |
02:36 ET | 1117 | 14.81 |
02:38 ET | 300 | 14.77 |
02:40 ET | 601 | 14.76 |
02:42 ET | 2669 | 14.81 |
02:44 ET | 495 | 14.8025 |
02:45 ET | 1109 | 14.84 |
02:47 ET | 500 | 14.84 |
02:49 ET | 500 | 14.82 |
02:51 ET | 4621 | 14.875 |
02:54 ET | 2367 | 14.925 |
02:56 ET | 895 | 14.94 |
02:58 ET | 2200 | 14.955 |
03:00 ET | 400 | 14.965 |
03:02 ET | 1338 | 14.965 |
03:03 ET | 2909 | 14.97 |
03:05 ET | 3940 | 14.98 |
03:07 ET | 973 | 15.01 |
03:09 ET | 4102 | 15.02 |
03:12 ET | 800 | 15.03 |
03:14 ET | 1410 | 15.045 |
03:16 ET | 3113 | 15 |
03:18 ET | 500 | 14.99 |
03:20 ET | 2452 | 14.995 |
03:21 ET | 909 | 14.99 |
03:23 ET | 1327 | 15.01 |
03:25 ET | 3206 | 14.99 |
03:27 ET | 500 | 14.99 |
03:30 ET | 3091 | 14.95 |
03:32 ET | 2333 | 14.95 |
03:34 ET | 2877 | 14.999 |
03:36 ET | 2431 | 15.01 |
03:38 ET | 1694 | 15.01 |
03:39 ET | 2364 | 15.02 |
03:41 ET | 4155 | 15.028 |
03:43 ET | 1485 | 15.02 |
03:45 ET | 1603 | 15.03 |
03:48 ET | 6821 | 15.03 |
03:50 ET | 7404 | 15.019 |
03:52 ET | 8497 | 14.965 |
03:54 ET | 8186 | 15.0674 |
03:56 ET | 10177 | 15.07 |
03:57 ET | 20636 | 15.04 |
03:59 ET | 23154 | 15.07 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.4B | -4.9x | --- |
Vir Biotechnology Inc | 1.4B | -2.6x | --- |
Ardelyx Inc | 1.6B | -23.8x | --- |
Prothena Corporation PLC | 1.1B | -6.4x | --- |
Gyre Therapeutics Inc | 971.4M | -6.0x | --- |
Xencor Inc | 1.5B | -10.8x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $237.0M |
Shares Outstanding | 91.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.85 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -113.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.